BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28629920)

  • 1. Pulmonary Hypertension in Parenchymal Lung Diseases: Any Future for New Therapies?
    Harari S; Elia D; Humbert M
    Chest; 2018 Jan; 153(1):217-223. PubMed ID: 28629920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials in group 3 pulmonary hypertension.
    Harder EM; Waxman AB
    Curr Opin Pulm Med; 2020 Sep; 26(5):391-396. PubMed ID: 32657833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation.
    Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R
    Respiration; 2016; 91(1):9-17. PubMed ID: 26492415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Hypertension Complicating Connective Tissue Disease.
    Volkmann ER; Chung A; Saggar R; Belperio JA; Lynch JP
    Semin Respir Crit Care Med; 2017 Oct; 38(5):619-635. PubMed ID: 29032565
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary hypertension associated with lung diseases and hypoxemia.
    Cuttica MJ
    Heart Fail Rev; 2016 May; 21(3):299-308. PubMed ID: 27086030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension complicating connective tissue disease.
    Lynch JP; Belperio JA; Saggar R; Fishbein MC; Saggar R
    Semin Respir Crit Care Med; 2013 Oct; 34(5):581-99. PubMed ID: 24037627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension and right heart dysfunction in chronic lung disease.
    Zangiabadi A; De Pasquale CG; Sajkov D
    Biomed Res Int; 2014; 2014():739674. PubMed ID: 25165714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia- and non-hypoxia-related pulmonary hypertension - established and new therapies.
    Ghofrani HA; Voswinckel R; Reichenberger F; Weissmann N; Schermuly RT; Seeger W; Grimminger F
    Cardiovasc Res; 2006 Oct; 72(1):30-40. PubMed ID: 16934242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary hypertension in COPD and interstitial lung diseases].
    Markart P; Ghofrani HA; Grimminger F; Günther A
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S164-6. PubMed ID: 19718606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pulmonary hypertension.
    Hoeper MM; McLaughlin VV; Dalaan AM; Satoh T; Galiè N
    Lancet Respir Med; 2016 Apr; 4(4):323-36. PubMed ID: 26975811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Update: Current clinical developments in pulmonary hypertension].
    Dumitrescu D; Ghofrani HA; Grimminger F; Hoeper MM; Rosenkranz S
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S160-3. PubMed ID: 19718605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Pulmonary Arterial Hypertension-specific Therapy in Pulmonary Arterial Hypertension: A Meta-analysis of Randomized Controlled Trials.
    Liu HL; Chen XY; Li JR; Su SW; Ding T; Shi CX; Jiang YF; Zhu ZN
    Chest; 2016 Aug; 150(2):353-66. PubMed ID: 27048870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update pulmonary arterial hypertension : Definitions, diagnosis, therapy].
    Sommer N; Richter MJ; Tello K; Grimminger F; Seeger W; Ghofrani HA; Gall H
    Internist (Berl); 2017 Sep; 58(9):937-957. PubMed ID: 28819824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The current pharmacotherapy of pulmonary arterial hypertension].
    Betkier-Lipińska K; Ryczek R; Cwetsch A
    Pol Merkur Lekarski; 2015 Jan; 38(223):34-8. PubMed ID: 25763586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension complicating interstitial lung disease and COPD.
    Shino MY; Lynch JP; Saggar R; Abtin F; Belperio JA; Saggar R
    Semin Respir Crit Care Med; 2013 Oct; 34(5):600-19. PubMed ID: 24037628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study.
    Kimura M; Tamura Y; Takei M; Yamamoto T; Ono T; Fujita J; Kataoka M; Kuwana M; Satoh T; Fukuda K
    BMC Pulm Med; 2015 May; 15():62. PubMed ID: 25971443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Events in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    Rhee RL; Gabler NB; Praestgaard A; Merkel PA; Kawut SM
    Arthritis Rheumatol; 2015 Sep; 67(9):2457-65. PubMed ID: 26016953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy in pulmonary arterial hypertension.
    Pugh ME; Hemnes AR; Robbins IM
    Clin Chest Med; 2013 Dec; 34(4):841-55. PubMed ID: 24267308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension in chronic lung disease and hypoxia.
    Nathan SD; Barbera JA; Gaine SP; Harari S; Martinez FJ; Olschewski H; Olsson KM; Peacock AJ; Pepke-Zaba J; Provencher S; Weissmann N; Seeger W
    Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30545980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.